$2.22 Billion is the total value of DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s 91 reported holdings in Q3 2017. The portfolio turnover from Q2 2017 to Q3 2017 was 37.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AVXS | Sell | AVEXIS INC | $149,679,000 | -21.1% | 1,547,386 | -33.0% | 6.74% | -33.3% |
| MCK | Buy | MCKESSON CORP | $111,982,000 | +115.8% | 729,000 | +131.1% | 5.04% | +82.2% |
| MYL | Buy | MYLAN N V | $98,929,000 | +86.4% | 3,153,611 | +130.7% | 4.46% | +57.4% |
| HZNP | Sell | HORIZON PHARMA PLC | $87,708,000 | -17.9% | 6,917,070 | -23.1% | 3.95% | -30.6% |
| GKOS | Buy | GLAUKOS CORP | $83,392,000 | +124.8% | 2,527,032 | +182.5% | 3.76% | +89.8% |
| MNKKQ | Buy | MALLINCKRODT PUB LTD CO | $69,513,000 | +31.6% | 1,860,137 | +57.8% | 3.13% | +11.1% |
| DXCM | Buy | DEXCOM INC | $69,469,000 | +283.2% | 1,419,911 | +472.9% | 3.13% | +223.6% |
| HORIZON PHARMA INVT LTDnote 2.500% 3/1 | $66,895,000 | +4.5% | 74,100,000 | 0.0% | 3.01% | -11.7% | ||
| MYOK | Buy | MYOKARDIA INC | $58,492,000 | +1496.0% | 1,365,039 | +387.9% | 2.64% | +1251.3% |
| Buy | ISIS PHARMACEUTICALS INC DELnote 1.000%11/1 | $48,504,000 | +8.0% | 45,700,000 | +8.3% | 2.18% | -8.7% | |
| KEMPHARM INCnote 5.500% 2/0 | $45,688,000 | +3.2% | 75,000,000 | 0.0% | 2.06% | -12.8% | ||
| NXTM | Sell | NXSTAGE MEDICAL INC | $43,588,000 | -54.6% | 1,579,285 | -58.8% | 1.96% | -61.7% |
| BOLD | Sell | AUDENTES THERAPEUTICS INC | $42,727,000 | +29.2% | 1,525,410 | -11.8% | 1.92% | +9.1% |
| EDIT | EDITAS MEDICINE INC | $41,043,000 | +43.1% | 1,709,400 | 0.0% | 1.85% | +20.8% | |
| ACRS | Buy | ACLARIS THERAPEUTICS INC | $40,726,000 | +300.5% | 1,577,927 | +320.8% | 1.84% | +238.6% |
| Buy | INTERCEPT PHARMACEUTICALS INnote 3.250% 7/0 | $39,674,000 | +80.5% | 51,000,000 | +126.7% | 1.79% | +52.3% | |
| AVDL | AVADEL PHARMACEUTICALS PLCsponsored adr | $38,383,000 | -4.8% | 3,655,494 | 0.0% | 1.73% | -19.6% | |
| TRINITY BIOTECH INVT LTDnote 4.000% 4/0 | $38,190,000 | -0.6% | 48,000,000 | 0.0% | 1.72% | -16.1% | ||
| XENT | Buy | INTERSECT ENT INC | $37,692,000 | +13.4% | 1,210,000 | +1.7% | 1.70% | -4.3% |
| GWPH | Buy | GW PHARMACEUTICALS PLCads | $36,813,000 | +2.0% | 362,724 | +0.8% | 1.66% | -13.9% |
| ENDOLOGIX INCnote 3.250%11/0 | $35,030,000 | +2.1% | 40,500,000 | 0.0% | 1.58% | -13.8% | ||
| NEVRO CORPnote 1.750% 6/0 | $32,756,000 | +10.6% | 27,600,000 | 0.0% | 1.48% | -6.6% | ||
| ASND | Buy | ASCENDIS PHARMA A Ssponsored adr | $30,813,000 | +164.6% | 850,000 | +102.6% | 1.39% | +123.5% |
| AERI | Sell | AERIE PHARMACEUTICALS INC | $30,749,000 | -39.1% | 632,686 | -34.2% | 1.38% | -48.6% |
| ANAB | Buy | ANAPTYSBIO INC | $28,811,000 | +117.8% | 824,338 | +49.1% | 1.30% | +83.9% |
| NTRA | New | NATERA INC | $28,120,000 | – | 2,181,542 | +100.0% | 1.27% | – |
| DBVT | Sell | DBV TECHNOLOGIES S Asponsored adr | $27,836,000 | +17.2% | 655,897 | -1.4% | 1.25% | -1.0% |
| PODD | New | INSULET CORP | $27,375,000 | – | 497,000 | +100.0% | 1.23% | – |
| ARNA | Buy | ARENA PHARMACEUTICALS INC | $27,344,000 | +289.0% | 1,072,329 | +157.3% | 1.23% | +228.5% |
| LCI | Sell | LANNET INC | $26,813,000 | -13.8% | 1,453,259 | -4.6% | 1.21% | -27.1% |
| BCRX | Buy | BIOCRYST PHARMACEUTICALS | $26,071,000 | +34.0% | 4,975,451 | +42.2% | 1.17% | +13.1% |
| New | K2M GROUP HLDGS INCnote 4.125% 8/1 | $24,498,000 | – | 20,000,000 | +100.0% | 1.10% | – | |
| XLRN | New | ACCELERON PHARMA INC | $22,952,000 | – | 615,000 | +100.0% | 1.03% | – |
| SEM | Buy | SELECT MED HLDGS CORP | $22,936,000 | +196.1% | 1,194,609 | +136.7% | 1.03% | +150.1% |
| PDCO | Buy | PATTERSON COMPANIES INC | $21,876,000 | +18.5% | 566,000 | +43.9% | 0.98% | 0.0% |
| FLUIDIGM CORP DELnote 2.750% 2/0 | $20,260,000 | +17.7% | 27,715,000 | 0.0% | 0.91% | -0.5% | ||
| SYRS | SYROS PHARMACEUTICALS INC | $18,679,000 | -8.5% | 1,268,945 | 0.0% | 0.84% | -22.8% | |
| MOH | Buy | MOLINA HEALTHCARE INC | $17,740,000 | +69.1% | 258,000 | +70.1% | 0.80% | +42.7% |
| SELB | Sell | SELECTA BIOSCIENCES INC | $17,367,000 | -17.5% | 951,629 | -10.2% | 0.78% | -30.4% |
| AACH | Sell | AAC HLDGS INC | $17,211,000 | +25.7% | 1,733,276 | -12.3% | 0.78% | +6.2% |
| REPH | RECRO PHARMA INC | $17,077,000 | +27.7% | 1,901,685 | 0.0% | 0.77% | +7.9% | |
| SYBX | New | SYNLOGIC INC | $16,165,000 | – | 850,143 | +100.0% | 0.73% | – |
| PTLA | Sell | PORTOLA PHARMACEUTICALS INC | $16,130,000 | -31.5% | 298,545 | -28.7% | 0.73% | -42.1% |
| EHTH | Sell | EHEALTH INC | $16,078,000 | +23.9% | 672,994 | -2.5% | 0.72% | +4.6% |
| OXFD | OXFORD IMMUNOTEC GLOBAL PLC | $15,888,000 | -0.1% | 945,710 | 0.0% | 0.72% | -15.6% | |
| New | AMAG PHARMACEUTICALS INCnote 3.250% 6/0 | $15,747,000 | – | 16,250,000 | +100.0% | 0.71% | – | |
| LOXO | Sell | LOXO ONCOLOGY INC | $15,568,000 | -22.7% | 169,000 | -32.7% | 0.70% | -34.7% |
| ARDX | Buy | ARDELYX INC | $15,380,000 | +32.3% | 2,746,480 | +20.5% | 0.69% | +11.8% |
| AAAP | Sell | ADVANCED ACCELERATOR APPLICsponsored ads | $14,741,000 | -3.9% | 218,000 | -44.5% | 0.66% | -18.8% |
| NEOS | Buy | NEOS THERAPEUTICS INC | $14,356,000 | +34.8% | 1,568,921 | +7.5% | 0.65% | +13.9% |
| BPMC | BLUEPRINT MEDICINES CORP | $14,143,000 | +37.5% | 203,000 | 0.0% | 0.64% | +16.0% | |
| AGIO | New | AGIOS PHARMACEUTICALS INC | $13,884,000 | – | 208,000 | +100.0% | 0.62% | – |
| CTMX | CYTOMX THERAPEUTICS INC | $13,751,000 | +17.2% | 756,822 | 0.0% | 0.62% | -1.1% | |
| AEGERION PHARMACEUTICALS INCnote 2.000% 8/1 | $13,359,000 | -0.8% | 16,600,000 | 0.0% | 0.60% | -16.2% | ||
| EPZM | Buy | EPIZYME INC | $13,345,000 | +33.4% | 700,526 | +5.8% | 0.60% | +12.5% |
| GLPG | Sell | GALAPAGOS NVspon adr | $13,228,000 | -7.8% | 130,000 | -30.7% | 0.60% | -22.1% |
| WVE | Sell | WAVE LIFE SCIENCES LTD | $12,615,000 | -9.2% | 580,000 | -22.3% | 0.57% | -23.3% |
| XNCR | Sell | XENCOR INC | $11,964,000 | +0.8% | 522,000 | -7.2% | 0.54% | -14.8% |
| ARGX | ARGENX SEsponsored adr | $11,509,000 | +6.6% | 509,022 | 0.0% | 0.52% | -10.1% | |
| ALPN | New | ALPINE IMMUNE SCIENCES INC | $10,824,000 | – | 933,100 | +100.0% | 0.49% | – |
| IVTY | INVUITY INC | $10,477,000 | +22.8% | 1,177,229 | 0.0% | 0.47% | +3.7% | |
| ALLSCRIPTS HEALTHCARE SOLUTNnote 1.250% 7/0 | $10,297,000 | +4.8% | 9,671,000 | 0.0% | 0.46% | -11.5% | ||
| CNC | Sell | CENTENE CORP DEL | $9,871,000 | +3.8% | 102,000 | -14.3% | 0.44% | -12.2% |
| SGMO | Sell | SANGAMO THERAPEUTICS INC | $9,795,000 | +1.7% | 653,000 | -40.3% | 0.44% | -14.2% |
| NVTA | New | INVITAE CORP | $8,433,000 | – | 900,000 | +100.0% | 0.38% | – |
| ALIM | Buy | ALIMERA SCIENCES INC | $8,171,000 | +23.2% | 6,052,935 | +26.9% | 0.37% | +4.0% |
| IMMU | New | IMMUNOMEDICS INC | $8,136,000 | – | 582,000 | +100.0% | 0.37% | – |
| MRNS | New | MARINUS PHARMACEUTICALS INC | $7,954,000 | – | 1,355,000 | +100.0% | 0.36% | – |
| CMTA | New | CLEMENTIA PHARMACEUTICALS IN | $7,810,000 | – | 462,387 | +100.0% | 0.35% | – |
| NCNA | New | NUCANA PLCsponsored adr | $7,806,000 | – | 424,950 | +100.0% | 0.35% | – |
| AXGT | Buy | AXOVANT SCIENCES LTD | $7,238,000 | +30.5% | 1,052,000 | +339.8% | 0.33% | +10.1% |
| AXGN | Sell | AXOGEN INC | $6,665,000 | -41.0% | 344,428 | -48.9% | 0.30% | -50.2% |
| MCK | New | MCKESSON CORPcall | $6,636,000 | – | 43,200 | +100.0% | 0.30% | – |
| MYOV | MYOVANT SCIENCES LTD | $6,199,000 | +32.2% | 400,685 | 0.0% | 0.28% | +11.6% | |
| BHVN | Sell | BIOHAVEN PHARMACTL HLDG CO L | $6,168,000 | +13.8% | 165,000 | -23.9% | 0.28% | -3.8% |
| DCPH | New | DECIPHERA PHARMACEUTICALS IN | $6,172,000 | – | 325,000 | +100.0% | 0.28% | – |
| RETA | New | REATA PHARMACEUTICALS INCcl a | $5,909,000 | – | 190,000 | +100.0% | 0.27% | – |
| AGRX | Buy | AGILE THERAPEUTICS INC | $5,449,000 | +52.1% | 1,221,775 | +27.9% | 0.24% | +28.3% |
| STDY | Sell | STEADYMED LTD | $4,753,000 | -47.7% | 1,418,787 | -1.6% | 0.21% | -55.9% |
| FOMX | FOAMIX PHARMACEUTICALS LTD | $4,537,000 | +19.6% | 817,435 | 0.0% | 0.20% | +1.0% | |
| SRRA | Sell | SIERRA ONCOLOGY INC | $4,340,000 | +6.1% | 2,800,000 | -19.9% | 0.20% | -10.6% |
| SAGE | New | SAGE THERAPEUTICS INC | $4,236,000 | – | 68,000 | +100.0% | 0.19% | – |
| ARLZ | ARALEZ PHARMACEUTICALS INC | $3,766,000 | +69.6% | 1,644,583 | 0.0% | 0.17% | +44.1% | |
| OBLN | Buy | OBALON THERAPEUTICS INC | $3,348,000 | +84.6% | 351,284 | +91.9% | 0.15% | +55.7% |
| BIOS | Sell | BIOSCRIP INC | $3,045,000 | -15.5% | 1,107,166 | -16.6% | 0.14% | -28.6% |
| AKTX | Sell | AKARI THERAPEUTICS PLCsponsored adr | $2,662,000 | -29.4% | 433,551 | -47.0% | 0.12% | -40.3% |
| PRTO | PROTEON THERAPEUTICS INC | $2,450,000 | +31.2% | 1,224,899 | 0.0% | 0.11% | +10.0% | |
| VYGR | VOYAGER THERAPEUTICS INC | $2,422,000 | +129.8% | 117,647 | 0.0% | 0.11% | +94.6% | |
| ITCI | New | INTRA CELLULAR THERAPIES INC | $1,864,000 | – | 118,116 | +100.0% | 0.08% | – |
| MDXG | New | MIMEDX GROUP INC | $1,782,000 | – | 150,000 | +100.0% | 0.08% | – |
| RARX | Buy | RA PHARMACEUTICALS INC | $1,491,000 | -3.7% | 102,150 | +23.7% | 0.07% | -19.3% |
| PTI | Exit | PROTEOSTASIS THERAPEUTICS IN | $0 | – | -17,251 | -100.0% | -0.00% | – |
| Exit | ESSA PHARMA INC | $0 | – | -1,416,230 | -100.0% | -0.04% | – | |
| BCRX | Exit | BIOCRYST PHARMACEUTICALScall | $0 | – | -500,000 | -100.0% | -0.15% | – |
| KMPH | Exit | KEMPHARM INC | $0 | – | -704,612 | -100.0% | -0.15% | – |
| JNCE | Exit | JOUNCE THERAPEUTICS INC | $0 | – | -247,872 | -100.0% | -0.19% | – |
| MNKD | Exit | MANNKIND CORP | $0 | – | -2,702,403 | -100.0% | -0.20% | – |
| NVLS | Exit | NIVALIS THERAPEUTICS INC | $0 | – | -3,732,412 | -100.0% | -0.48% | – |
| PBYI | Exit | PUMA BIOTECHNOLOGY INCput | $0 | – | -104,000 | -100.0% | -0.48% | – |
| ANTM | Exit | ANTHEM INC | $0 | – | -75,182 | -100.0% | -0.75% | – |
| AET | Exit | AETNA INC NEW | $0 | – | -130,000 | -100.0% | -1.05% | – |
| NVRO | Exit | NEVRO CORP | $0 | – | -376,308 | -100.0% | -1.49% | – |
| GILD | Exit | GILEAD SCIENCES INCcall | $0 | – | -750,000 | -100.0% | -2.83% | – |
| GILD | Exit | GILEAD SCIENCES INC | $0 | – | -938,515 | -100.0% | -3.54% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-11-13
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AERIE PHARMACEUTICALS INC | 36 | Q3 2022 | 3.6% |
| CENTENE CORP DEL | 30 | Q3 2023 | 3.0% |
| BIOCRYST PHARMACEUTICALS INC | 29 | Q3 2023 | 2.2% |
| MOLINA HEALTHCARE INC | 26 | Q3 2022 | 1.7% |
| EHEALTH INC | 25 | Q3 2020 | 2.0% |
| INTERCEPT PHARMACEUTICALS IN | 24 | Q1 2023 | 2.2% |
| MYLAN NV | 23 | Q3 2020 | 6.2% |
| PORTOLA PHARMACEUTICALS INC | 23 | Q1 2019 | 6.0% |
| BROOKDALE SR LIVING INC | 23 | Q3 2023 | 2.2% |
| ALIMERA SCIENCES INC | 23 | Q3 2019 | 0.8% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| DA32 Life Science Tech Acquisition Corp. | August 01, 2023 | 5,145,000 | 91.1% |
| CareMax, Inc. | March 13, 2023 | 18,691,423 | 16.4% |
| CareMax, Inc. | June 02, 2022 | 18,691,423 | 20.7% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 3 | 2024-03-19 |
| 4 | 2024-03-19 |
| 4 | 2024-03-12 |
| 3 | 2024-03-08 |
| 4 | 2024-02-16 |
| 13F-HR | 2024-02-14 |
| 4 | 2024-02-08 |
| 3 | 2024-02-01 |
| 4 | 2023-11-21 |
| 13F-HR | 2023-11-14 |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.